| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,864 |
4,722 |
$242K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,049 |
2,977 |
$239K |
| 99051 |
|
3,320 |
3,265 |
$97K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
122 |
122 |
$11K |
| 87428 |
|
328 |
328 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
484 |
478 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
161 |
159 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
324 |
161 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
13 |
$314.22 |
| 96127 |
|
31 |
31 |
$24.64 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
26 |
26 |
$21.56 |
| 96160 |
|
30 |
30 |
$21.44 |
| G9920 |
Screening performed and negative |
25 |
25 |
$0.00 |
| 90661 |
|
14 |
14 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
12 |
12 |
$0.00 |
| 92551 |
|
61 |
61 |
$0.00 |
| 90686 |
|
14 |
14 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
14 |
$0.00 |